Team:UNIPV-Pavia/Project/solution

From 2010.igem.org

(Difference between revisions)
(Validation of pir strains to propagate the R6K replication origin)
m (Integrative standard vector for E. coli)
 
(118 intermediate revisions not shown)
Line 25: Line 25:
<td  align="center"><br>
<td  align="center"><br>
<html><a href="https://2010.igem.org/Team:UNIPV-Pavia/Project/results">
<html><a href="https://2010.igem.org/Team:UNIPV-Pavia/Project/results">
-
<img src="https://static.igem.org/mediawiki/2010/e/e1/UNIPV_Pavia_result_BN.jpg" width="75px" height="75px" alt="Results" title="Results"/>
+
<img src="https://static.igem.org/mediawiki/2010/e/e1/UNIPV_Pavia_result_BN.jpg" width="75px" height="75px" alt="Implementation & Results" title="Implementation & Results"/>
</a>
</a>
</html></td>
</html></td>
Line 34: Line 34:
</tr>
</tr>
</table>
</table>
 +
 +
<html><a name="indice"/></a></html>
<p align="center" valign="top"><br>
<p align="center" valign="top"><br>
Line 40: Line 42:
<br>
<br>
<hr>
<hr>
 +
 +
Several solutions were explored in this project to potentially improve the industrial production of recombinant proteins.
 +
 +
Self-inducible promoters were considered to avoid the usage of inducible systems especially in large-scale industrial bioprocesses, in which protein production has to be triggered by expensive inducer molecules.
 +
 +
Standard and user friendly integrative vectors for E. coli and S. cerevisiae were designed to stably integrate the expression systems of interest in the microbial host genome and to eliminate the need of expensive selection techniques, such as antibiotics or auxotrophic media.
 +
 +
Finally, an "in-cell" protein purification system was implemented using BioBrick parts: PolyHydroxyAlkanoate (PHA) granules were used as a substrate for PHA-binding peptides (Phasins) fused to the target protein, while a pH-based self-cleaving peptide (Intein) was used instead of a protease cleavage site. This solution can thus replace the usage of expensive affinity resins/columns and proteases.
 +
<table align="center" border="0"  width="80%">
<table align="center" border="0"  width="80%">
Line 48: Line 59:
</html>
</html>
<br>
<br>
-
[[Team:UNIPV-Pavia/Project/solution #Self-inducible promoters|Self-inducible promoters]]
+
[[#Self-inducible promoters|Self-inducible promoters]]
</td>
</td>
<td  align="center" valign = "center" style="padding:20px" width="25%">
<td  align="center" valign = "center" style="padding:20px" width="25%">
Line 55: Line 66:
</html>
</html>
<br>
<br>
-
[[Team:UNIPV-Pavia/Project/solution #Integrative standard vector for E. coli|Integrative standard vector for E. coli]]
+
[[#Integrative standard vector for E. coli|Integrative standard vector for E. coli]]
</td>
</td>
<td  align="center" valign = "center" style="padding:20px" width="25%">
<td  align="center" valign = "center" style="padding:20px" width="25%">
Line 62: Line 73:
</html>
</html>
<br>
<br>
-
[[Team:UNIPV-Pavia/Project/solution #Integrative standard vector for yeast|Integrative standard vector for yeast]]
+
[[#Integrative standard vector for yeast|Integrative standard vector for yeast]]
</td>
</td>
<td  align="center" valign = "center" style="padding:20px" width="25%">
<td  align="center" valign = "center" style="padding:20px" width="25%">
Line 69: Line 80:
</html>
</html>
<br>
<br>
-
[[Team:UNIPV-Pavia/Project/solution #Self-cleaving affinity tags to easily purify proteins|Purification of proteins]]
+
[[#Self-cleaving affinity tags to easily purify proteins|Purification of proteins]]
</td>
</td>
</tr>
</tr>
Line 77: Line 88:
<table align="center" border="0" width="80%">
<table align="center" border="0" width="80%">
-
<html><a name="indice"/></html>
+
 
<html>
<html>
<img src="https://static.igem.org/mediawiki/2010/7/7b/UNIPV_Pavia_Icona_PromotoriAuto.GIF" width="55px" height="70px"/>
<img src="https://static.igem.org/mediawiki/2010/7/7b/UNIPV_Pavia_Icona_PromotoriAuto.GIF" width="55px" height="70px"/>
</html>
</html>
 +
=Self-inducible promoters=
=Self-inducible promoters=
 +
 +
The aim of this section is the realization and characterization of a library of self-inducible promoters. These devices are promoters able to initiate the production of the target protein when the cell culture reaches the desired culture density.
 +
 +
===<b>Exploiting quorum sensing mechanism...</b>===
 +
 +
Different studies demonstrated that many bacteria can communicate through a mechanism called ''quorum sensing'' and can regulate gene expression relying on cell culture density. One of the most studied organisms is ''V. fischeri'', for which the quorum sensing is regulated by two genes: luxI and luxR. The first one encodes a protein responsible for the synthesis of 3-oxo-C6-homoserine-lactone (3OC6HSL or simply HSL), a small molecule called ''autoinducer''. The second one encodes a protein capable to bind the HSL. The ''lux pR'' promoter, which is normally off, can be activated by the LuxR-HSL complex when the autoinducer reaches a critical concentration.
 +
 +
When a cell population expresses luxI, the concentration of HSL is an increasing function of cell culture density and so the induction of the ''lux pR'' promoter occurs only when the cells reach a threshold density.
 +
 +
Taking inspiration from this natural regulation mechanism, a library of self-inducible devices was built by engineering quorum sensing circuits in ''E. coli''. The critical cell density was modulated by changing the autoinducer molecule synthesis rate. In this way, the library members can initiate the ''lux pR'' gene expression at different cell densities of the host strain. In ''V. fischeri'', the ''lux pR'' regulates a set of genes involved in the bioluminescence of the bacteria, but in synthetic circuits based on this regulatory mechanism users can regulate the expression of the desired genes (Fig.1).
 +
 +
 +
 +
[[Image:pv_SenderReceiverAntenna.png|450px|thumb|center|Figure 1: Sender/receiver behaviour exploited to obtain self-inducible devices]]
 +
 +
===<b>Parts and system overview</b>===
 +
 +
Two BioBrick parts already present in the Registry were used in this module. The RBS-luxI part (<partinfo>BBa_K081008</partinfo>) was assembled upstream of the double terminator <partinfo>BBa_B0015</partinfo>, thus obtaining the fundamental part to build self-inducible circuits, <partinfo>BBa_K300009</partinfo> (Fig.2).
 +
[[Image:pv_K300009.png|230px|thumb|center|Figure 2: <partinfo>BBa_K300009</partinfo> PoPS->HSL sender device.]]
 +
 +
This part was used as signal generator, while the signal receiver part is <partinfo>BBa_F2620</partinfo> and is shown in Fig.3.
 +
 +
[[Image:pv_F2620.png|350px|thumb|center|Figure 3: <partinfo>BBa_F2620</partinfo> receiver device.]]
 +
 +
 +
In order to build a library of self-inducible devices, another foundamental device was obtained by assembling <partinfo>BBa_K300009</partinfo> upstream of <partinfo>BBa_F2620</partinfo>, thus obtaining the part <partinfo>BBa_K300010</partinfo> (Fig.4).
 +
 +
[[Image:pv_K300010.png|450px|thumb|center|Figure 4: <partinfo>BBa_K300010</partinfo>, a PoPS-based self-inducible device.]]
 +
 +
These systems have the behaviour shown in Fig.5: luxR is constitutively produced under the control of the tetR promoter, while luxI is produced under the control of a different constitutive promoter.
 +
 +
The HSL synthesis rate was modulated by assembling constitutive promoters of different strength upstream of luxI gene. In this way, the ''lux pR'' can be activated when the HSL concentration in the growth media is greater than a threshold, which changes as a function of the HSL synthesis rate. The constitutive promoters were chosen from the ''Anderson Promoters Collection'', available in the Registry.
 +
 +
[[Image:pv_I80_working.png|450px|thumb|center|Figure 5: Self-inducible devices behaviour. ''Pcon'' is a generic constitutive promoter.]]
 +
 +
Besides the use of constitutive promoters of different strength to regulate the production of the signal molecule, the plasmid copy number was taken into consideration as another important parameter. The studied combinations are summarized in Fig.6, 7 and 8.
 +
 +
{| align='center'
 +
|[[Image:pv_HCHC.png|330px|thumb|center|Figure 6: Both sender and receiver are assembled on high copy number plasmid. ]]||[[Image:pv_LCLC.png|330px|thumb|center|Figure 7: Both sender and receiver are assembled on low copy number plasmid.]]
 +
|}
 +
{| align='center'
 +
|[[Image:pv_HCLC.png|330px|thumb|center|Figure 8: Sender part in low copy number plasmid and receiver on high copy number plasmid.]]
 +
|}
 +
 +
Thus, these BioBrick parts can be used to express recombinant proteins without adding an inducer to trigger the transcription initiation of downstream genes; in large-scale production of such proteins this strategy can be cost saving and ease the entire process. Users can rationally choose the cell density at which the initiation has to occur by selecting a self-inducible device library member.
 +
 +
{| align='center'
 +
|[[Image:pv_curva_od_stilizzata.png|500px|thumb|center|Figure 9: behaviour of self-inducible device library members. Each device is able to initiate the synthesis of the recombinant protein of interest at a specific cell density.]]
 +
|}
 +
<div align="right"><small>[[#indice|^top]]</small></div>
<div align="right"><small>[[#indice|^top]]</small></div>
Line 87: Line 149:
<img src="https://static.igem.org/mediawiki/2010/8/8b/UNIPV_Pavia_Icona_intColi.GIF" width="55px" height="70px"/>
<img src="https://static.igem.org/mediawiki/2010/8/8b/UNIPV_Pavia_Icona_intColi.GIF" width="55px" height="70px"/>
</html>
</html>
-
=Integrative standard vector for E. coli=
+
 
 +
=Integrative standard vector for ''E. coli''=
The integration of the genetic circuits of interest into the microbial host genome can eliminate the need of expensive selection techniques, such as antibiotics or auxotrophic media, in cell cultures.
The integration of the genetic circuits of interest into the microbial host genome can eliminate the need of expensive selection techniques, such as antibiotics or auxotrophic media, in cell cultures.
-
In order to simplify the engineering of the host genome, two standard and modular integrative vectors have been designed for Escherichia coli and Saccharomyces cerevisiae, two commonly used hosts for industrial protein production. Here, a detailed description of the integrative vector for ''E. coli'' is reported, while the following section deals with the integrative vector for yeast.
+
In order to simplify the engineering of the host genome, two standard and modular integrative vectors have been designed for Escherichia coli and Saccharomyces cerevisiae, two commonly used hosts for industrial protein production. Here, a detailed description of the integrative vector for ''E. coli'' is reported, while the following section deals with the integrative vector for yeast. The parts notation is reported in Fig.11.
-
The structure of the designed vector, here named <partinfo>BBa_K300000</partinfo>, is shown in Fig.1. Most of its features have been inspired by <partinfo>BBa_I51020</partinfo> (BioBrick base vector) and <partinfo>BBa_J72007</partinfo> (BamHI methyltransferase encoding CRIM plasmid), described by [Shetty RP et al., 2008] and [Anderson JC et al., 2010] respectively.
+
The structure of the designed vector, here named <partinfo>BBa_K300000</partinfo>, is shown in Fig.10. Most of its features have been inspired by <partinfo>BBa_I51020</partinfo> (BioBrick base vector) and <partinfo>BBa_J72007</partinfo> (BamHI methyltransferase encoding CRIM plasmid), described by [Shetty RP et al., 2008] and [Anderson JC et al., 2010] respectively.  
{|align=center
{|align=center
-
|valign=top|[[Image:k300000.jpg|thumb|500px|center|Figure 1: BioBrick integrative base vector BBa_K300000.]]
+
|valign=top|[[Image:k300000.jpg|thumb|500px|center|Figure 10: BioBrick integrative base vector <partinfo>BBa_K300000</partinfo>.]]
-
|[[Image:glossary300000.jpg|thumb|300px|center|Figure 2: Parts notation.]]
+
|[[Image:glossary300000.jpg|thumb|300px|center|Figure 11: Parts notation.]]
|}
|}
Line 112: Line 175:
 +
===Design features===
The main design features for vector engineering and for the genome integration of the vector are reported below.
The main design features for vector engineering and for the genome integration of the vector are reported below.
Line 131: Line 195:
<partinfo>BBa_K300000</partinfo> can be:
<partinfo>BBa_K300000</partinfo> can be:
-
*propagated in E. coli
+
*propagated in ''E. coli''
-
*engineered to change the passenger and/or the integration guide
+
*engineered to change the ''passenger'' and/or the integration ''guide''
*integrated into the desired locus of the host genome
*integrated into the desired locus of the host genome
*used to perform the desired number of serial integrations in the same genome
*used to perform the desired number of serial integrations in the same genome
 +
===How to propagate it before performing genome integration===
===How to propagate it before performing genome integration===
Line 146: Line 211:
{|align=center
{|align=center
-
|[[Image:guide.jpg|thumb|800px|center|Figure 3: How to engineer the integrative base vector to assemble the desired DNA ''guide''.]]
+
|[[Image:guide.jpg|thumb|800px|center|Figure 12: How to engineer the integrative base vector to assemble the desired DNA ''guide''.]]
|}
|}
-
#Be sure to have the desired ''guide'' in the RFC10 standard or a compatible one (Fig.3-a).
+
#Be sure to have the desired ''guide'' in the RFC10 standard or a compatible one (Fig.12-a).
-
#Digest the ''guide'' with XbaI-SpeI (Fig.3-b).
+
#Digest the ''guide'' with XbaI-SpeI (Fig.12-b).
-
#Digest the integrative base vector <partinfo>BBa_K300000</partinfo> with NheI (Fig.3-c) and dephosphorylate the linearized vector to prevent re-ligation.
+
#Digest the integrative base vector <partinfo>BBa_K300000</partinfo> with NheI (Fig.12-c) and dephosphorylate the linearized vector to prevent re-ligation.
-
#Ligate the digestion products (Fig.3-d). XbaI, SpeI and NheI all have compatible protruding ends. Note that the ligation is not directional, but the ''guide'' can work in both directions.
+
#Ligate the digestion products (Fig.12-d). XbaI, SpeI and NheI all have compatible protruding ends. Note that the ligation is not directional, but the ''guide'' can work in both directions.
#Transform the ligation in a ''ccdB''-tolerant strain and screen the clone.
#Transform the ligation in a ''ccdB''-tolerant strain and screen the clone.
Line 159: Line 224:
{|align=center
{|align=center
-
|[[Image:passenger.jpg|thumb|800px|center|Figure 4: How to engineer the integrative base vector to assemble the desired DNA ''passenger''.]]
+
|[[Image:passenger.jpg|thumb|800px|center|Figure 13: How to engineer the integrative base vector to assemble the desired DNA ''passenger''.]]
|}
|}
-
#Be sure to have the desired ''passenger'' in the RFC10 standard or a compatible one (Fig.4-a).
+
#Be sure to have the desired ''passenger'' in the RFC10 standard or a compatible one (Fig.13-a).
-
#Digest the ''passenger'' with EcoRI-PstI (Fig.4-b).
+
#Digest the ''passenger'' with EcoRI-PstI (Fig.13-b).
-
#Digest the integrative base vector <partinfo>BBa_K300000</partinfo> with EcoRI-PstI (Fig.4-c).
+
#Digest the integrative base vector <partinfo>BBa_K300000</partinfo> with EcoRI-PstI (Fig.13-c).
-
#Ligate the digestion products (Fig.4-d).
+
#Ligate the digestion products (Fig.13-d).
#Transform the ligation in a pir+/pir-116 strain. Transformants with the uncut plasmid contaminant DNA do not grow because of the ''ccdB'' toxin in <partinfo>BBa_I52002</partinfo>. Screen the clone.
#Transform the ligation in a pir+/pir-116 strain. Transformants with the uncut plasmid contaminant DNA do not grow because of the ''ccdB'' toxin in <partinfo>BBa_I52002</partinfo>. Screen the clone.
Line 187: Line 252:
This integration method is applicable when the host strain does not have prophages in the att(Phi80) locus. TOP10 (<partinfo>BBa_V1009</partinfo>) and DH5alpha (<partinfo>BBa_V1001</partinfo>) strains have the Phi80 prophage and so their chromosome cannot be engineered with this procedure.
This integration method is applicable when the host strain does not have prophages in the att(Phi80) locus. TOP10 (<partinfo>BBa_V1009</partinfo>) and DH5alpha (<partinfo>BBa_V1001</partinfo>) strains have the Phi80 prophage and so their chromosome cannot be engineered with this procedure.
-
The genomic integration of the desired BioBrick part into the attP(Phi80) locus has to be mediated by co-transforming a helper plasmid (such as the Amp-resistant <partinfo>BBa_J72008</partinfo> plasmid) carrying the IntPhi80 site-specific integrase gene under the control of a thermoinducible promoter (see Fig.5). The helper plasmid also has a heat-sensitive replication origin, whose replication can be inhibited at temperatures of 37-42°C, while a permissive temperature for this vector is 30°C. For this reason, it can be cured at high temperatures, when the integrase expression is triggered at the same time.
+
The genomic integration of the desired BioBrick part into the attP(Phi80) locus has to be mediated by co-transforming a helper plasmid, such as the Amp-resistant <partinfo>BBa_J72008</partinfo> plasmid, which carries the IntPhi80 site-specific integrase gene under the control of a thermoinducible promoter (see Fig.14). The helper plasmid also has a heat-sensitive replication origin, whose replication can be inhibited at temperatures of 37-42°C, while a permissive temperature for this vector is 30°C. For this reason, it can be cured at high temperatures, when the integrase expression is triggered at the same time.
-
The Phi80 integrase mediates the site-specific recombination between the attP site in the integrative vector and the attB site in the bacterial genome (for a schematic description of this process, see Fig.6 and http://partsregistry.org/Recombination).
+
The Phi80 integrase mediates the site-specific recombination between the attP site in the integrative vector and the attB site in the bacterial genome (for a schematic description of this process, see Fig.15 and http://partsregistry.org/Recombination).
{|align=center
{|align=center
-
|[[Image:k300000helper.jpg|thumb|500px|center|Figure 5: Schematic description of the <partinfo>BBa_J72008</partinfo> plasmid. ???]]
+
|valign=top|[[Image:k300000helper.jpg|thumb|330px|center|Figure 14: Schematic description of the <partinfo>BBa_J72008</partinfo> plasmid. ''cI857'' is the expression system for the thermoinducible cI repressor; ''int'' is the Phi80 integrase regulated by the lambda cI-repressible promoter; ''pir'' is the expression system for the pir-116 gene which is able to trigger the propagation of the R6K conditional replication origin; ''ori_ts'' is the heat-sensitive replication origin (low copy) of the vector; ''bla'' is the Ampicillin resistance marker.]]
-
|}
+
|valign=top|[[Image:k300000recombsite.jpg|thumb|500px|center|Figure 15: Schematic description of site-specific recombination between a bacteriophage attP attachment site in the plasmid and an attB attachment site in the bacterial genome. In this way the sequence of interest (called "Part" in the figure) can be stably integrated into the attB genomic locus. This process is mediated by a specific integrase.]]
-
 
+
-
{|align=center
+
-
|[[Image:k300000recombsite.jpg|thumb|500px|center|Figure 6: Schematic description of site-specific recombination between a bacteriophage attP attachment site in the plasmid and an attB attachment site in the bacterial genome. This process is mediated by a specific integrase.]]
+
|}
|}
Thanks to its R6K conditional replication origin, the integrative vector cannot be replicated in common ''E. coli'' strains, so the Chloramphenicol resistant bacteria are actual integrants.
Thanks to its R6K conditional replication origin, the integrative vector cannot be replicated in common ''E. coli'' strains, so the Chloramphenicol resistant bacteria are actual integrants.
-
In the Materials and Methods section, a detailed protocol to target the desired BioBrick part into the Phi80 locus is reported.
+
In the Materials and Methods section (https://2010.igem.org/Team:UNIPV-Pavia/Project/results), a detailed protocol to target the desired BioBrick part into the Phi80 locus is reported.
 +
 
 +
===How to perform multiple integrations in the same genome===
 +
When this vector is integrated in the genome, the desired ''passenger'' should be maintained into the host, as well as the Chloramphenicol resistance marker and the R6K conditional replication origin. The CmR and the R6K can be excised from the genome by exploiting the two FRT recombination sites that flank them. The Flp recombinase protein mediates this recombination event (for a schematic description of this process, see Fig.16 and http://partsregistry.org/Recombination), so it has to be expressed by a helper plasmid, such as pCP20 (CGSC#7629).
 +
This enables the sequential integration of several parts using the same antibiotic resistance marker, which can be each time eliminated.
 +
 
-
===How to perform multiple integration in the same genome===
 
-
When this vector is integrated into the genome, the desired ''passenger'' should be maintained into the host, as well as the Chloramphenicol resistance marker and the R6K conditional replication origin. The CmR and the R6K can be excised from the genome by exploiting the two FRT recombination sites that flank them. The Flp recombinase protein mediates this recombination event, so it has to be expressed by a helper plasmid, such as pCP20 (CGSC#7629).
 
-
This enables the sequential integration of several parts using the same antibiotic resistance marker, which can be eliminated each time.
 
Detailed protocols about homologous recombination can be found here:
Detailed protocols about homologous recombination can be found here:
Line 211: Line 275:
-
==Materials and Methods==
 
-
'''Plasmids and strains:''' the <partinfo>BBa_J72008</partinfo> helper plasmid was kindly given by Prof. JC Anderson (UC Berkeley). MC1061 (<partinfo>BBa_K300078</partinfo>) and MG1655 (<partinfo>BBa_V1000</partinfo>) E. coli strains and the pCP20 helper plasmid were purchased from the Coli Genetic Stock Center (Yale University). DH5alpha (<partinfo>BBa_V1001</partinfo>) strain was purchased from Invitrogen.
+
{|align=center
 +
|[[Image:k300000recombfrt.jpg|thumb|500px|center|Figure 16: Schematic description of direct repeat-recombination between two FRT sites which flank the R6K-CmR DNA. In this way, the R6K-CmR DNA is excised from the construct and a single FRT site remains in the molecule. This process is mediated by a specific recombinase, the Flp recombinase, which recognizes the FRT sites.]]
 +
|}
-
'''Verification primers:''' all the oligonucleotides were purchased from Primm (San Raffaele Biomedical Science Park, Milan, Italy). The P1 (<partinfo>BBa_K300975</partinfo>) and P4 (<partinfo>BBa_K300978</partinfo>) primers had already been used in [Anderson JC et al., 2010]. The P2 (<partinfo>BBa_K300976</partinfo>) and P3 (<partinfo>BBa_K300977</partinfo>) primers have been newly designed using ApE and amplifiX. P2 and P3 have been designed also considering the previously used verification primers P2 and P3 in the pG80ko integrative plasmid, described in [DeLoache W, 2009].
+
<div align="right"><small>[[#indice|^top]]</small></div>
 +
<html>
 +
<img src="https://static.igem.org/mediawiki/2010/0/03/UNIPV_Pavia_Icona_IntYeast.GIF" width="55px" height="70px"/>
 +
</html>
-
'''Competent cells preparation:''' all the ''E. coli'' strains were made competent following a slightly modified version of the protocol described in [Sambrook J et al., 1989]. Briefly, cells were grown to and OD600 of ~0.4-0.6, harvested (4000 rpm, 10 min, 4°C) and the supernatant discarded. Cells were resuspended in (30 ml for each 50 ml of initial culture) pre-chilled Mg-Ca buffer (80 mM MgCl2, 20 mM CaCl2), centrifuged as before and the supernatant discarded. Cells were resuspended in (2 ml for each 50 ml of initial culture) pre-chilled Ca buffer (100 mM CaCl2, 15% glycerol), aliquoted in 0.5 ml tubes and freezed immediately at -80°C. Test the transformation efficiency as:
+
=Integrative standard vector for yeast=
-
<div align=center>
+
-
''efficiency [CFU/ug of DNA]= # CFU * 1000 ng of DNA / amount of transformed DNA [ng]''
+
-
</div>
+
 +
Here, a detailed description of the integrative vector for the yeast ''S. cerevisiae'' is reported.
-
'''Pir strains validation:''' in order to test the capability of BW25141 (pir+) and BW23474 (pir-116) to propagate this conditional replication origin, they were made competent, as well as three control strains: MC1061, MG1655 and DH5alpha. Then, a vial of 100 ul of competent cells was transformed with 2-4 ng of:
+
The structure of the designed vector, here named <partinfo>BBa_K300001</partinfo>, is shown in Fig.17. Most of its features have been inspired by the pUG6 plasmid (GenBank: AF298793.1), constructed by [Guldener U et al., 1996]. The parts notation is reported in Fig.18.
-
*no DNA (negative control);
+
-
*a pSB*** series vector (positive control);
+
-
*self-ligated <partinfo>BBa_K300008</partinfo> (a R6K plasmid with Cm resistance).
+
-
Self-ligated <partinfo>BBa_K300008</partinfo> was prepared by digesting <partinfo>pSB1A2</partinfo>-<partinfo>BBa_K300008</partinfo> (yielded by BioBrick Standard Assembly) with XbaI-SpeI. The insert was isolated and purified from a 1% agarose gel. Then, it was self-ligated to generate a Cm-resistant R6K plasmid. The colonies were counted in each plate and the transformation efficiency was estimated as described before.
+
{|align=center
 +
|valign=top|[[Image:k300001base.jpg|thumb|500px|center|Figure 17: BioBrick integrative base vector <partinfo>BBa_K300001</partinfo>.]]
 +
|[[Image:glossary300001.jpg|thumb|300px|center|Figure 18: Parts notation.]]
 +
|}
 +
This is an integrative vector which can be used to insert the desired RFC10-compatible BioBrick parts/devices/systems into the genome of ''S. cerevisiae''. This vector can also be specialized to target the desired integration site in the host genome.
-
'''BBa_K300000 construction:''' This section describes how this vector backbone was assembled using BioBrick parts.
+
The default version of this backbone targets the Gal system of the S288C strain (<partinfo>BBa_K300979</partinfo>) through the two homologous regions <partinfo>BBa_K300986</partinfo> and <partinfo>BBa_K300987</partinfo>. The Gal system is not essential for yeast survival if the strain is grown on carbon sources other than galactose.
-
#'''First step - <partinfo>BBa_K300982</partinfo> intermediate part construction:'''
+
-
##<partinfo>BBa_K300983</partinfo>, provided by Mr Gene DNA synthesis service (www.mrgene.com), was excised from its original shipping vector (pMK-RQ) through digestion with AvrII restriction enzyme (Roche). It was then isolated through a 1% agarose gel electrophoresis and gel-extracted (Macherey-Nagel NucleoSpin Extract II).
+
-
##<partinfo>BBa_K300008</partinfo> was assembled via BioBrick Standard Assembly from available parts and was excised from its vector (<partinfo>pSB1A2</partinfo>) through digestion with XbaI-SpeI (Roche). It was then isolated using the same procedure described above and it was dephosphorylated by using Antarctic Phosphatase (NEB).
+
-
##Digested <partinfo>BBa_K300983</partinfo> and <partinfo>BBa_K300008</partinfo>, all having compatible sticky ends, were ligated with T4 Ligase (Roche) and transformed into competent BW23474 E. coli strain (<partinfo>BBa_K300985</partinfo>) in order to allow the ligated plasmid propagation at high copy number. This strain was necessary because the replication origin of the resulting plasmid was the conditional R6K origin (<partinfo>BBa_J61001</partinfo>).
+
-
##Positive transformants, grown on Chloramphenicol (34 ug/ml) plates, were identified by restriction mapping with EcoRI-HindIII (Roche). The yielded plasmid was <partinfo>BBa_K300982</partinfo>.
+
-
#'''Second step - <partinfo>BBa_K300000</partinfo> final vector construction:'''
+
-
##<partinfo>BBa_K300982</partinfo> DNA was miniprepped, digested with EcoRI-PstI (Roche), run on agarose gel and gel-extracted as described above, in order to cut out and eliminate the RBS (<partinfo>BBa_B0033</partinfo>) between EcoRI and PstI.
+
-
##<partinfo>BBa_I52002</partinfo> DNA was excised from <partinfo>pSB4C5</partinfo> by EcoRI-PstI (Roche) digestion and isolated by gel run and gel extraction as described above.
+
-
##Digested <partinfo>BBa_K300982</partinfo> and <partinfo>BBa_I52002</partinfo> were ligated and transformed into competent DB3.1 E. coli strain (<partinfo>BBa_V1005</partinfo>), selected with Chloramphenicol at 34 ug/ml.
+
-
##Positive transformants were screened by restriction mapping with EcoRI-HindIII (Roche) and sequencing with VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00101</partinfo>) standard primers. The yielded plasmid was <partinfo>BBa_K300000</partinfo>.
+
-
All the DNA manipulations were performed according to manufacturer's protocols.
+
This vector enables multiple integrations in different positions of the same genome. The usage of the KanMX dominant selection marker can avoid the usage of auxotrophic markers. In the industrial framework auxotrophies are usually deleterious for the process productivity because they affect the growth rate of cells. For this reason, this vector can be a concrete solution for the design of industrial yeast strains with novel user-defined functions.
-
'''Integration protocol:'''
+
===Glossary===
 +
A ''HR'' (Homologous Region) is a sequence that can recombine with the host genome.
-
# Transform the <partinfo>BBa_J72008</partinfo> helper plasmid in the host strain (MC1061 or MG1655) and select transformants on Amp (50 ug/ml) plates under permissive conditions (30°C) overnight.
+
As explained for the integrative vector for ''E. coli'', the ''passenger'' is the desired DNA part to be integrated into the genome.
-
# Inoculate a single colony in selective LB and let the culture grow at 30°C, 220 rpm. When the culture reaches the OD600 of 0.4-0.6 prepare chemically competent cells.
+
-
# Transform the integrative vector with the desired insert in the BBa_J72008-containing strain and select co-transformants on Cm (34 ug/ml) plates under permissive conditions (30°C) overnight. At this temperature <partinfo>BBa_J72008</partinfo> can be replicated and so the pir protein product can be expressed in the cells. The pir product enables the propagation of the integrative vector by replicating the R6K origin.
+
-
# Inoculate a single colony in 5 ml of LB + Cm at 12.5 ug/ml and incubate the culture at 37°C, 220 rpm overnight. At this temperature the <partinfo>BBa_J72008</partinfo> helper cannot be replicated and the Phi80 integrase is expressed by the remaining copies of the helper. The bacteria that are able to grow in this selective medium should be correct integrants because the integrative vector cannot be replicated by the pir product anymore.
+
-
# Streak the culture on a Cm plate (at 12.5 ug/ml) and incubate it at 43°C overnight to ensure the loss of the helper plasmid. The bacteria that form colonies should be correct integrants without the <partinfo>BBa_J72008</partinfo> helper plasmid.
+
-
Validate the loss of the helper plasmid by inoculating colonies in Cm (at 12.5 ug/ml) media and counterselecting them in Amp (at 50 ug/ml) media. Validate the correct integration position by performing colony PCR with primers P1/P2, P3/P4, P1/P4, P2,P3 and VF2/VR. Validate the phenotype (when possible).
+
===Design features===
 +
This vector backbone was designed as a modular integrative vector for ''S. cerevisiae''. In this section, the main design features for vector engineering and for the genome integration of the vector are reported.
-
Expected amplicon length [bp] when the vector is integrated into the Phi80 locus:
 
-
{|border=1
 
-
|&nbsp;
 
-
|'''No integrant'''
 
-
|'''Single integrant'''
 
-
|'''Multiple tandem integrants (>1)'''
 
-
|-
 
-
|'''VF2/VR'''
 
-
|none
 
-
|280 + insert length
 
-
|280 + insert length
 
-
|-
 
-
|'''P1/P4'''
 
-
|546
 
-
|546 + insert length + 2171 (i.e. the BBa_K300000 length)
 
-
|546 + insert length + 2171 (i.e. the BBa_K300000 length)
 
-
|-
 
-
|'''P1/P2'''
 
-
|none
 
-
|452
 
-
|452
 
-
|-
 
-
|'''P3/P4'''
 
-
|none
 
-
|666
 
-
|666
 
-
|-
 
-
|'''P2/P3'''
 
-
|none
 
-
|none
 
-
|572
 
-
|}
 
 +
''Vector engineering features:''
 +
#The '''cloning site''' is not the same as other RFC10 compatible vectors. It contains a '''RFC10 BioBrick Prefix (<partinfo>BBa_G00000</partinfo>) and a SpeI restriction site''' instead of the original BioBrick Suffix. However, the presence of unique EcoRI and SpeI sites in the cloning site '''fully supports the assembly of the desired BioBrick parts in the cloning site upon EcoRI-SpeI digestion'''. This design feature has been forced by the presence of illegal XbaI and PstI sites in the TEF promoter in the LoxP-KanMX-LoxP cassette (<partinfo>BBa_K300989</partinfo>). This vector '''does not support the 3A Assembly'''.
 +
#The two '''NheI''' sites and the two '''AvrII''' sites flanking the default HR integration sequences <partinfo>BBa_K300986</partinfo> and <partinfo>BBa_K300987</partinfo> enable the '''engineering of this backbone by assembling new user-defined BioBrick integration sequences upon XbaI-SpeI digestion'''.
 +
#This vector '''can be propagated in ''E. coli'' at high copy''' thanks to the pMB1 replication origin and the Ampicillin resistance marker present in <partinfo>pSB1A2</partinfo> (=<partinfo>BBa_K300988</partinfo>), that is one of the standard parts that compose this integrative vector.
 +
#Standard verification primer binding sites VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00102</partinfo>) are present in the <partinfo>pSB1A2</partinfo> (=<partinfo>BBa_K300988</partinfo>) backbone. They can be used to '''verify the vector length and sequence comprised between the two integration sites'''.
-
'''Marker excision protocol:'''
 
-
# Inoculate an integrant in selective LB medium and let it grow to OD600=0.4-0.6. Prepare chemically competent cells.
+
''Genome integration features:''
-
# Transform the pCP20 helper plasmid in the competent strain and select transformants on Amp (100 ug/ml) plates under permissive conditions (30°C) overnight. At this temperature the pCP20 can be replicated. The pCP20 plasmid contains Amp and Cm resistance markers, a thermoinducible Flp recombinase expression system and a heat-sensitive replication origin. The permissive temperatures for the pCP20 propagation are the same as <partinfo>BBa_J72008</partinfo>.
+
#The LoxP-KanMX-LoxP cassette (<partinfo>BBa_K300989</partinfo>) enables the '''selection of positive yeast integrants on YPD agar plates supplemented with 200 ug/ml of G418 geneticin'''. Once integrated, this cassette can be '''excised upon Cre recombinase activity'''. This allows to perform multiple integrations in the same strain, always using the same dominant G418 resistance marker.
-
# Inoculate a single colony in 5 ml of LB without antibiotic and incubate the culture at 37°C, 220 rpm overnight. At this temperature the pCP20 helper cannot be replicated and the Flp recombinase is expressed by the remaining copies of the helper. The bacteria that should loose the R6K origin and the Cm resistance upon FRT sites recombination, mediated by Flp.
+
#The heterologous modules in the LoxP-KanMX-LoxP cassette (<partinfo>BBa_K300989</partinfo>), i.e. the TEF promoter and the TEF transcriptional terminator from ''A. gossypii'' and the KanR from the Tn903 transposon of ''E. coli'', show a very low homology with the ''S. cerevisiae'' genome. For this reason, the '''vector integration events in unwanted positions in the yeast genome are limited'''.
-
# Streak the culture on a LB plate and incubate it at 43°C overnight to ensure the loss of the helper plasmid. The bacteria that form colonies should be without the pCP20 helper plasmid.
+
-
Validate the loss of the helper plasmid by inoculating colonies in Amp (at 100 ug/ml) media and validate the loss of the Cm resistance from the genome by inoculating colonies in Cm (at 12.5 ug/ml) media. Validate the correct length of the integrated part without Cm resistance and R6K origin by performing colony PCR with primers P1/P4 (which amplify the entire Phi80 locus) and VF2/VR (which amplify the integrated part). Validate the phenotype (when possible).
+
 +
==How to use it==
-
'''Colony PCR:''' a single colony or 1 ul of culture was added to the Invitrogen Platinum Taq reaction mix and was heated at 94°C for 10 min. Then it was assayed with this cycle (X 35): 94°C 30 sec, 60°C (for VF2/VR) or 63°C (for the other primers) 30 sec, 72°C according to the amplicon expected length (1Kb/min). Then the reaction was kept at 72°C for 10 min and it was run on a 1% agarose gel with the GeneRuler 1Kb Plus DNA ladder (Fermentas).
+
<partinfo>BBa_K300001</partinfo> can be:
 +
*propagated in ''E. coli''
 +
*engineered to change the ''passenger'' part and/or the ''HR''s.
 +
*integrated into the desired locus of the host genome
 +
*used to perform the desired number of serial integrations in the same genome
-
'''Fluorescence assays:''' integrants were inoculated in 1 ml of M9 + Cm (12.5 ug/ml) and grown at 37°C, 220 rpm overnight. The cultures were diluted 1:100 in 1 ml of selective M9 and let grow for about 4 hours under the same conditions as before. Three 200 ul aliquots for each culture were transferred to a 96-well microplate and assayed in the Infinite F200 microplate reader (Tecan) for about 20 hours with the following kinetic cycle: 37°C, 5 min sampling time, linear shaking 15 sec (amplitude=3), wait 5 sec, measure OD600, measure fluorescence with the proper filter (EX:nm/EM:540nm for GFP or EX:535nm/EM:620nm for RFP) with gain=50 or 70. The same protocol was followed for the MC1061 and the MG1655 non-integrant strains, which were grown in M9 without antibiotic.
 
-
==Results==
+
===How to propagate it before performing genome integration===
 +
This vector can be easily propagated in ''E. coli'' thanks to the high-copy replication origin and the Ampicillin resistance selection marker, both derived from the <partinfo>pSB1A2</partinfo> vector backbone.
-
===Validation of pir strains to propagate the R6K replication origin===
+
 
-
The BW25141 (pir+) and BW23474 (pir-116) ''E. coli'' strains were chosen to propagate the vectors with the R6K replication origin at medium copy (~15 molecules per cell) and high copy (~250) respectively.
+
===How to integrate a BioBrick into the yeast genome===
-
The results about their capability to propagate R6K plasmids are shown here:
+
#Digest <partinfo>BBa_K300001</partinfo> and the desired BioBrick part with EcoRI-SpeI and ligate them (Fig.19).
-
{|border=1
+
#Propagate the resulting plasmid in ''E. coli'' and extract plasmid DNA from bacteria.
-
|'''Strain'''
+
#Digest the resulting plasmid with SbfI to linearize the DNA of interest (Fig.20). This is known to increase the integration efficiency from 10- to 50-fold when compared to a non-linearized DNA [http://partsregistry.org/Part:BBa_K300001:Design#References Reference 11].
-
|'''Efficiency with no DNA'''
+
#Transform the linearized plasmid into ''S. cerevisiae'' and select integrants on G418 antibiotic plates (Fig.21).
-
|'''Efficiency with pSB*** (positive control)'''
+
 
-
|'''Efficiency with the self-ligated <partinfo>BBa_K300008</partinfo> (R6K plasmid)'''
+
{|align=center
-
|-
+
|[[Image:k300001.jpg|thumb|500px|center|Figure 19: Assembly of the desired BioBrick part into the integrative vector.]]
-
|BW25141 (<partinfo>BBa_K300084</partinfo>, pir+)
+
-
|0
+
-
|10^5
+
-
|10^5
+
-
|-
+
-
|BW23474 (<partinfo>BBa_K300085</partinfo>, pir-116)
+
-
|0
+
-
|10^6
+
-
|10^6
+
-
|-
+
-
|DH5alpha (<partinfo>BBa_V1001</partinfo>, neg control)
+
-
|0
+
-
|10^8
+
-
|0
+
-
|-
+
-
|MC1061 (<partinfo>BBa_K300078</partinfo>, neg control)
+
-
|0
+
-
|10^6
+
-
|0
+
-
|-
+
-
|MG1655 (<partinfo>BBa_V1000</partinfo>, neg control)
+
-
|0
+
-
|10^5
+
-
|six small colonies from 2 ng of DNA
+
|}
|}
-
These results show that the R6K conditional replication origin can be only propagated in pir+ and pir-116 strains (<partinfo>BBa_K300084</partinfo> and <partinfo>BBa_K300085</partinfo>), while the transformation of other strains with the R6K plasmid yielded no colonies after transformation. The exception was MG1655, for which six small unwanted colonies appeared on the selective plate. Plasmid DNA was purified/HindIII-digested/gel-run for at least one colony for BW25141-<partinfo>BBa_K300008</partinfo> and BW23474-<partinfo>BBa_K300008</partinfo>, while all the six colonies were analyzed for MG1655-<partinfo>BBa_K300008</partinfo> plate. The electrophoresis showed the expected length of the transformed DNA for all the clones except for the MG1655 six colonies, for which a smear was present in the lane (data not shown). Probably, Cm-resistant contaminants were present in the MG1655 culture during the preparation of competent cells.
+
{|align=center
 +
|[[Image:linear300001.jpg|thumb|600px|center|Figure 20: The plasmid can be linearized upon SbfI digestion to separate the yeast DNA fragment (containing the part of interest and the LoxP-KanMX-LoxP cassette) from the ''E. coli'' DNA fragment (containing the replication origin and the Amp resistance).]]
 +
|}
-
For this reason, competent cells were prepared again for MG1655 and the transformation procedure was repeated for this strain, yielding no colonies in the <partinfo>BBa_K300008</partinfo> plate as expected.
+
{|align=center
 +
|[[Image:recomb300001.jpg|thumb|600px|center|Figure 21: Integration of the BioBrick of interest into the ''S. cerevisiae'' genome by homologous recombination. In this figure, the integration in the Gal system genomic region is shown.]]
 +
|}
-
Miniprep of the BW25141 and BW23474 strains transformed with <partinfo>BBa_K300008</partinfo> yielded a DNA concentration of ~20 ng/ul (qualitatively comparable with medium copy number plasmids) and ~90-100 ng/ul (qualitatively comparable with high copy number plasmids).
+
Users can change the integration site by engineering the vector: <partinfo>BBa_K300986</partinfo> and <partinfo>BBa_K300987</partinfo> are flanked by two AvrII and two NheI respectively and for this reason the two Homologous Regions can be excided. New homologous sequences compatible with RFC10 can be digested with XbaI-SpeI and assembled because AvrII, NheI, XbaI and SpeI have compatible sticky ends. Note that this assembly is not directional and the correct orientation can be validated through sequencing with standard VF2 and VR primers.
-
The results shown in the table above also show that the R6K plasmid in pir+ and pir-116 strains was transformed with the same efficiency as the pSB*** positive control plasmid, demonstrating that the R6K origin doesn't give any handicap in plasmid transformation.
+
-
So, the BW25141 and BW23474 strains can be successfully used to propagate the integrative vector after the excision of the pUC19-derived high copy replication origin, present in the default insert <partinfo>BBa_I52002</partinfo>.
+
-
===Integration of the desired BioBrick part into the Phi80 genome locus===
 
-
===Integration of the desired BioBrick part into the Phi80 genome locus===
+
===How to perform the KanMX marker excision===
 +
The KanMX dominant selection marker is flanked by two loxP recombination sites and for this reason it can be excided upon Cre recombinase activity (Fig.22). The Cre recombinase has to be expressed by a helper plasmid.
-
'''Validation of the loss of BBa_J72008'''
 
-
'''Validation of the actual integration site'''
+
{|align=center
 +
|[[Image:loxp300001.jpg|thumb|600px|center|Figure 22: KanMX excision with loxP sites recombination. For more details about this process, see http://partsregistry.org/Recombination]]
 +
|}
-
'''Validation of the integrants phenotype'''
 
-
===Chloramphenicol resistance marker excision===
+
<div align="right"><small>[[#indice|^top]]</small></div>
-
'''Validation of the loss of pCP20 and the resistance marker'''
+
<html>
 +
<img src="https://static.igem.org/mediawiki/2010/7/74/UNIPV_Pavia_Icona_Bioplastica.GIF" width="75px" height="75px"/></a>
 +
</html>
-
'''Validation of the marker-less phenotype'''
+
=Self-cleaving affinity tags to easily purify proteins=
 +
Conventional affinity-based protein purification methods rely on specific binding of the fusion tag to an immobilized ligand, but they are affected by severe limitations, as explained in the Motivation section. Briefly, they imply the use of expensive proteases for tag removal from the fusion protein, requiring the appropriate aminoacidic sequence to be included between the tag and the target protein. Moreover, the cost of the affinity resins used in the process is far from negligible, especially on industrial scale.
 +
The use of self-cleaving protein elements coupled with innovative affinity tags has been recently proposed to overcome these limitations. For all these reasons, in this section a technique compliant to the BioBrick assembly standard and based on self-splicing affinity tags derived from the fusion of Phasins, Inteins and a short flexible linker is proposed.
-
==Discussion==
+
==Tag==
 +
===Phasin===
 +
Phasins are proteins involved in formation and stabilization of PolyHydroxyAlkanoates (PHA), intracytoplasmic inclusions in microorganisms like ''Ralstonia eutropha'' which serve as carbon and energy storage. As such, Phasins exhibit highly specific binding to PHA granules and can be used to create tags for proteins, while PHB can be used as the affinity matrix.
-
A novel integrative vector for ''E. coli'' has been successfully designed, constructed and used to integrate two proof of concept protein expression systems in two commonly used E. coli strains.
+
In literature, it has also been shown that the Phasin-tagged fusion protein's affinity with PHA granules can be improved by increasing the number of Phasins in the fusion protein.
-
The results showed that the vector is fully functional and can integrate into the correct targeted locus of the host chromosome through the Phi80 site-specific recombination system by using <partinfo>BBa_J72008</partinfo>, an existing BioBrick helper plasmid from the Registry. In most cases, the integration occurs in tandem copies, probably because of the too high Chloramphenicol concentration used during the selection of integrants, which forces multiple integration of Cm-resistant constructs. This concentration was the same used during the pSC101 low copy plasmid (~5 copies per cell) selection. In some cases, it is desirable to have a single copy of the desired BioBrick in the genome, for example when the gene dosage is important. In [Haldimann A and Wanner BL, 2001] the usage of Chloramphenicol at 6 ug/ml yielded a very high percentage of single integrants. However, when tested in our lab, the MG1655 strain could survive on LB plates with Cm at 6 ug/ml and also at 8 ug/ml. For this reason a higher concentration of Cm was chosen for selection. Further studies should investigate the optimal antibiotic concentration to yield the highest single integrants percentage as possible.
+
The ''Ralstonia eutropha''‘s Phasin coding sequence, <partinfo>K208001</partinfo>, was already present in the Registry in Silver standard. However, at the end of this gene there was a TGA stop codon which prevents the usage of this Phasin as a head or internal domain.
 +
In order to overcome this problem, <partinfo>K208001</partinfo> has been improved for fusion protein applications by mutagenesis through PCR using custom primers. Two new BioBrick parts were built and submitted to the Registry:
-
The Flp/FRT mediated excision of the R6K and, most importantly, of the Cm resistance marker also worked by using the pCP20 helper plasmid. The estimated efficiency of this process was 100%. In addition, multiple tandem integrants became single integrants after the marker excision. This is because the Flp recombinase mediated the recombination of all the FRT sites of the multiple integrants until only a single FRT site was present in the Phi80 locus. The marker excision is a powerful tool to engineer microbial strains for industrial protein manufacturing because the engineered organism should not carry unsafe antibiotic resistances that may be diffused in the environment.
+
* <partinfo>BBa_K300002</partinfo>: Phasin - head domain (removed stop codon; Assembly Standard 10 prefix; Silver Standard suffix)
 +
* <partinfo>BBa_K300003</partinfo>: Phasin - internal domain (removed stop codon; Silver Standard prefix; Silver Standard suffix)
 +
These two new parts allow the construction of composite synthetic affinity tags, built by assembling an arbitrary number of Phasins (it has been shown that a better affinity is achieved by fusing of two or more Phasins). In this work a flexible linker sequence (<partinfo>BBa_K105012</partinfo>) that connects the Phasins has also been used in order to test if it can improve or facilitate the binding and folding of the tag.
-
The fluorescence phenotype confirmed the correct integration into the E. coli chromosome. As expected, in general multiple integrants showed a higher fluorescence than the single integrants.
+
===PHA production===
 +
PHA production in ''R. eutropha'' is achieved by the PhaCAB operon, which contains three genes, phbC, phbA and phbB, each encoding for an enzyme essential for the formation of polyhydroxybutyrate (PHB, a kind of polyhydroxyalkanoate) inclusions. In literature, the production of PHB has already been achieved in ''E. coli'' by incorporating the PhaCAB operon. The PHB granules produced by engineered ''E. coli'' can be used as an affinity matrix for Phasin-based affinity tags and the binding of the Phasin-tagged protein of interest can occur ''in vivo''.
 +
Several parts for PHB production are present in the Registry: in the past iGEM editions, the Duke (2008 and 2009), Hawaii (2008), Tsinghua (2008), Virginia (2008) teams worked on it and submitted a set of BioBrick parts for PHB synthesis. However, the complete phaCAB operon is not available in the Registry. Because a lot of work about PHB has already been done and because our short term goal was not to optimize the PHB granules productions, an existing engineered ''E. coli'' strain able to produce PHB was used as a proof-of-concept affinity matrix producer. This strain comes from the DSMZ public collection and is named <html><a href="http://www.dsmz.de/microorganisms/plasmid_info.php?dsmz_no=15372" target="_blank">DMSZ15372</a></html>.
-
The BioBrick compatibility and the vector modularity give the possibility to the scientific community to stably engineer novel biological functions in E. coli with a very easy and user friendly methodology. A user’s handbook about the vector usage is shared in the Registry, as well as the users experiences and the compatibility information.
+
----
 +
Taking advantage of the natural affinity of Phasins to PHB, it is possible to engineer strains in which PHB and the Phasin-tagged protein of interest are co-produced and the binding can occur. The overall yield and specificity of the process depends on the structure of the Phasin-based tags, which can be easily constructed or modified by using BioBrick parts compatible with the common RFC10 and RFC23 standards to perform in-frame assemblies.
-
<div align="right"><small>[[#indice|^top]]</small></div>
+
For this reason these tags are modular and can be freely expanded; a generic one is shown in Fig.23.
-
<html>
+
[[Image:UNIPV10_generic_tag.jpg|thumb|170px|center|Figure 23: Generic tag composed by two Phasin coding sequences separated by a flexible peptide linker coding sequence.]]
-
<img src="https://static.igem.org/mediawiki/2010/0/03/UNIPV_Pavia_Icona_IntYeast.GIF" width="55px" height="70px"/>
+
 
-
</html>
+
==Protein purification system==
 +
Phasins and PHB granules can replace the common affinity tags and matrix respectively. However, expensive proteases are still essential to remove the tag after the Phasins-PHB binding. A novel engineered inducible Intein can be used to complete the purification process by removing the affinity tag, thus replacing proteases.
 +
===Intein===
 +
Inteins (Intervening Proteins) are sequences capable of self-exciding from a precursor protein through a process known as self-splicing, forming a peptide bond between the flanking proteins (exteins). Many so-called mini-Inteins have been engineered, whose key feature is the capability to completely release a flanking extein (the target protein) in response to a simple stimulus, either chemical or physical, with no need of expensive proteases.
 +
 
 +
In literature, one mini-Intein was obtained through mutagenesis of ''Mycobacterium tuberculosis'' ''Mtu RecA'' Intein. The sequence of this Intein, referred to as ΔI-CM, allows for pH/heat-controlled C-terminal cleavage.
 +
 
 +
Thanks to this feature, the ΔI-CM Intein can be fused downstream of an affinity tag and upstream of the protein coding sequence of interest in order to enable a cheap cleavage process to remove the N-terminal tag.
 +
 
 +
In this project, the ΔI-CM Intein sequence was designed according to [Wood DW et al., 1999] and codon-optimized for ''E. coli'' to yield <partinfo>BBa_K300004</partinfo>. This part was designed as an internal domain (prefix and suffix compatible with Silver standard) in order to enable protein coding sequence assemblies to generate the desired synthetic self-cleavable affinity tags for protein purification.
 +
 
 +
----
 +
 
 +
Thus, it is possible to create an engineered protein purification system that uses the tag construct and relies on Intein self-cleaving capabilities. Fig.24 shows a generic purification tag, composed by Phasins and Intein, as an example.
 +
[[Image:UNIPV10_generic_purification.jpg|thumb|400px|center|Figure 24: Generic purification system.]]
 +
 
 +
Protein purification takes place as follows:
 +
:1. Affinity tag (and consequently fused protein) binding to PolyHydroxyAlkanoates (Fig.25).
 +
[[Image:UNIPV10_binding_activity.png|thumb|400px|center|Figure 25: ''In vivo'' binding activity.]]
 +
:2. Cells lysis.
 +
:3. Recovery of the fused protein, bound with PHA granules, by centrifugation.
 +
:4. Elution in the supernatant of the target protein by Intein cleavage through a pH or heat stimulus (Fig.26).
 +
[[Image:UNIPV10_purification_step.png|thumb|150px|center|Figure 26: Purification.]]
-
=Integrative standard vector for yeast=
 
-
<div align="right"><small>[[#indice|^top]]</small></div>
 
-
<html>
 
-
<img src="https://static.igem.org/mediawiki/2010/7/74/UNIPV_Pavia_Icona_Bioplastica.GIF" width="75px" height="75px"/></a>
 
-
</html>
 
-
=Self-cleaving affinity tags to easily purify proteins=
 
<div align="right"><small>[[#indice|^top]]</small></div>
<div align="right"><small>[[#indice|^top]]</small></div>

Latest revision as of 17:20, 26 October 2010




ProteInProgress: a cellular assembly line for protein manufacturing



Motivation Solutions
Implementation & Results

References


Solutions



Several solutions were explored in this project to potentially improve the industrial production of recombinant proteins.

Self-inducible promoters were considered to avoid the usage of inducible systems especially in large-scale industrial bioprocesses, in which protein production has to be triggered by expensive inducer molecules.

Standard and user friendly integrative vectors for E. coli and S. cerevisiae were designed to stably integrate the expression systems of interest in the microbial host genome and to eliminate the need of expensive selection techniques, such as antibiotics or auxotrophic media.

Finally, an "in-cell" protein purification system was implemented using BioBrick parts: PolyHydroxyAlkanoate (PHA) granules were used as a substrate for PHA-binding peptides (Phasins) fused to the target protein, while a pH-based self-cleaving peptide (Intein) was used instead of a protease cleavage site. This solution can thus replace the usage of expensive affinity resins/columns and proteases.



Self-inducible promoters


Integrative standard vector for E. coli


Integrative standard vector for yeast


Purification of proteins


Self-inducible promoters

The aim of this section is the realization and characterization of a library of self-inducible promoters. These devices are promoters able to initiate the production of the target protein when the cell culture reaches the desired culture density.

Exploiting quorum sensing mechanism...

Different studies demonstrated that many bacteria can communicate through a mechanism called quorum sensing and can regulate gene expression relying on cell culture density. One of the most studied organisms is V. fischeri, for which the quorum sensing is regulated by two genes: luxI and luxR. The first one encodes a protein responsible for the synthesis of 3-oxo-C6-homoserine-lactone (3OC6HSL or simply HSL), a small molecule called autoinducer. The second one encodes a protein capable to bind the HSL. The lux pR promoter, which is normally off, can be activated by the LuxR-HSL complex when the autoinducer reaches a critical concentration.

When a cell population expresses luxI, the concentration of HSL is an increasing function of cell culture density and so the induction of the lux pR promoter occurs only when the cells reach a threshold density.

Taking inspiration from this natural regulation mechanism, a library of self-inducible devices was built by engineering quorum sensing circuits in E. coli. The critical cell density was modulated by changing the autoinducer molecule synthesis rate. In this way, the library members can initiate the lux pR gene expression at different cell densities of the host strain. In V. fischeri, the lux pR regulates a set of genes involved in the bioluminescence of the bacteria, but in synthetic circuits based on this regulatory mechanism users can regulate the expression of the desired genes (Fig.1).


Figure 1: Sender/receiver behaviour exploited to obtain self-inducible devices

Parts and system overview

Two BioBrick parts already present in the Registry were used in this module. The RBS-luxI part (<partinfo>BBa_K081008</partinfo>) was assembled upstream of the double terminator <partinfo>BBa_B0015</partinfo>, thus obtaining the fundamental part to build self-inducible circuits, <partinfo>BBa_K300009</partinfo> (Fig.2).

Figure 2: <partinfo>BBa_K300009</partinfo> PoPS->HSL sender device.

This part was used as signal generator, while the signal receiver part is <partinfo>BBa_F2620</partinfo> and is shown in Fig.3.

Figure 3: <partinfo>BBa_F2620</partinfo> receiver device.


In order to build a library of self-inducible devices, another foundamental device was obtained by assembling <partinfo>BBa_K300009</partinfo> upstream of <partinfo>BBa_F2620</partinfo>, thus obtaining the part <partinfo>BBa_K300010</partinfo> (Fig.4).

Figure 4: <partinfo>BBa_K300010</partinfo>, a PoPS-based self-inducible device.

These systems have the behaviour shown in Fig.5: luxR is constitutively produced under the control of the tetR promoter, while luxI is produced under the control of a different constitutive promoter.

The HSL synthesis rate was modulated by assembling constitutive promoters of different strength upstream of luxI gene. In this way, the lux pR can be activated when the HSL concentration in the growth media is greater than a threshold, which changes as a function of the HSL synthesis rate. The constitutive promoters were chosen from the Anderson Promoters Collection, available in the Registry.

Figure 5: Self-inducible devices behaviour. Pcon is a generic constitutive promoter.

Besides the use of constitutive promoters of different strength to regulate the production of the signal molecule, the plasmid copy number was taken into consideration as another important parameter. The studied combinations are summarized in Fig.6, 7 and 8.

Figure 6: Both sender and receiver are assembled on high copy number plasmid.
Figure 7: Both sender and receiver are assembled on low copy number plasmid.
Figure 8: Sender part in low copy number plasmid and receiver on high copy number plasmid.

Thus, these BioBrick parts can be used to express recombinant proteins without adding an inducer to trigger the transcription initiation of downstream genes; in large-scale production of such proteins this strategy can be cost saving and ease the entire process. Users can rationally choose the cell density at which the initiation has to occur by selecting a self-inducible device library member.

Figure 9: behaviour of self-inducible device library members. Each device is able to initiate the synthesis of the recombinant protein of interest at a specific cell density.

Integrative standard vector for E. coli

The integration of the genetic circuits of interest into the microbial host genome can eliminate the need of expensive selection techniques, such as antibiotics or auxotrophic media, in cell cultures.

In order to simplify the engineering of the host genome, two standard and modular integrative vectors have been designed for Escherichia coli and Saccharomyces cerevisiae, two commonly used hosts for industrial protein production. Here, a detailed description of the integrative vector for E. coli is reported, while the following section deals with the integrative vector for yeast. The parts notation is reported in Fig.11.


The structure of the designed vector, here named <partinfo>BBa_K300000</partinfo>, is shown in Fig.10. Most of its features have been inspired by <partinfo>BBa_I51020</partinfo> (BioBrick base vector) and <partinfo>BBa_J72007</partinfo> (BamHI methyltransferase encoding CRIM plasmid), described by [Shetty RP et al., 2008] and [Anderson JC et al., 2010] respectively.

Figure 10: BioBrick integrative base vector <partinfo>BBa_K300000</partinfo>.
Figure 11: Parts notation.

This vector can be considered as a base vector, which can be specialized to target the desired integration site in the host genome. The default version of this backbone has the bacteriophage Phi80 attP (<partinfo>BBa_K300991</partinfo>) as integration site.

This vector enables multiple integrations in different positions of the same genome.


Glossary

The passenger is the desired DNA part to be integrated into the genome.

The guide is the DNA sequence that is used to target the passenger into a specific locus in the genome.


Design features

The main design features for vector engineering and for the genome integration of the vector are reported below.

Vector engineering features:

  1. The cloning site is compatible with the original BioBrick standard (RFC10), i.e. it is composed by the BioBrick Prefix (<partinfo>BBa_G00000</partinfo>) and Suffix (<partinfo>BBa_G00001</partinfo>). The presence of illegal restriction sites (XbaI in <partinfo>BBa_J72001</partinfo> and SpeI in <partinfo>BBa_K300991</partinfo>) prevents the usage of this backbone in the classic BioBrick Standard Assembly process. However, the presence of unique EcoRI and PstI sites in Prefix and Suffix fully supports the assembly of the desired BioBrick parts in the cloning site upon EcoRI-PstI digestion and also supports the 3A Assembly.
  2. The two NheI restriction sites flanking the default integration guide sequence <partinfo>BBa_K300991</partinfo> enable the engineering of this backbone by assembling new user-defined BioBrick integration guides upon XbaI-SpeI digestion, if the desired guide conforms to the RFC10 or a compatible standard.
  3. The default insert <partinfo>BBa_I52002</partinfo> contains the positive selection marker <partinfo>BBa_P1016</partinfo> and the pUC19-derived replication origin <partinfo>BBa_I50022</partinfo>. <partinfo>BBa_P1016</partinfo> expresses the ccdB toxin gene, which is lethal for most E. coli strains and is useful to prevent the growth of transformants containing the uncut plasmid contaminant DNA. For this reason, the default vector must be propagated in ccdB-tolerant strains, such as DB3.1 (<partinfo>BBa_V1005</partinfo>). <partinfo>BBa_I50022</partinfo> enables the propagation of this vector at high copy in the used ccdB-tolerant strain.
  4. Like in many other standard vector backbones (e.g. the pSB**5 series), the binding sites for standard primers VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00102</partinfo>) are present upstream and downstream of the BioBrick cloning site respectively. These two sequences are sufficiently distant from the cloning site to enable a good quality sequencing of the insert.

Genome integration features:

  1. The four transcriptional terminators <partinfo>BBa_B0053</partinfo>, <partinfo>BBa_B0054</partinfo>, <partinfo>BBa_B0055</partinfo> and <partinfo>BBa_B0062</partinfo> ensure the transcriptional insulation of the integrated part from its flanking genome sequences.
  2. The two FRT recombination sites (<partinfo>BBa_J72001</partinfo>) enable the excision of <partinfo>BBa_K300994</partinfo>-<partinfo>BBa_K300998</partinfo>-<partinfo>BBa_G0001</partinfo>-<partinfo>BBa_B0025</partinfo>-<partinfo>BBa_G0001</partinfo>-<partinfo>BBa_K300999</partinfo>-<partinfo>BBa_K300995</partinfo> (i.e. the R6K origin and the Chloramphenicol resistance marker) upon Flp recombinase activity. This marker excision allows users to make multiple integrations in the same strain, always using the same antibiotic resistance marker.
  3. The engineering of the integration guide allows the integration of parts in user-defined genome positions and for this reason this vector supports the integration by exploiting bacteriophage attP-mediated integration as well as homologous recombination.


How to use it

<partinfo>BBa_K300000</partinfo> can be:

  • propagated in E. coli
  • engineered to change the passenger and/or the integration guide
  • integrated into the desired locus of the host genome
  • used to perform the desired number of serial integrations in the same genome


How to propagate it before performing genome integration

The default version of this vector contains the <partinfo>BBa_I52002</partinfo> insert, so it *must* be propagated in a ccdB-tolerant strain such as DB3.1 (<partinfo>BBa_V1005</partinfo>).

After the insertion of the desired BioBrick part in the cloning site, this vector does not contain a standard replication origin anymore, so it *must* be propagated in a pir+ or pir-116 strain such as BW25141 (<partinfo>BBa_K300984</partinfo>) or BW23474 (<partinfo>BBa_K300985</partinfo>) that can replicate the R6K conditional origin (<partinfo>BBa_J61001</partinfo>).


How to engineer it

The DNA guide can be changed as follows:

Figure 12: How to engineer the integrative base vector to assemble the desired DNA guide.
  1. Be sure to have the desired guide in the RFC10 standard or a compatible one (Fig.12-a).
  2. Digest the guide with XbaI-SpeI (Fig.12-b).
  3. Digest the integrative base vector <partinfo>BBa_K300000</partinfo> with NheI (Fig.12-c) and dephosphorylate the linearized vector to prevent re-ligation.
  4. Ligate the digestion products (Fig.12-d). XbaI, SpeI and NheI all have compatible protruding ends. Note that the ligation is not directional, but the guide can work in both directions.
  5. Transform the ligation in a ccdB-tolerant strain and screen the clone.


The DNA passenger can be changed as follows:

Figure 13: How to engineer the integrative base vector to assemble the desired DNA passenger.
  1. Be sure to have the desired passenger in the RFC10 standard or a compatible one (Fig.13-a).
  2. Digest the passenger with EcoRI-PstI (Fig.13-b).
  3. Digest the integrative base vector <partinfo>BBa_K300000</partinfo> with EcoRI-PstI (Fig.13-c).
  4. Ligate the digestion products (Fig.13-d).
  5. Transform the ligation in a pir+/pir-116 strain. Transformants with the uncut plasmid contaminant DNA do not grow because of the ccdB toxin in <partinfo>BBa_I52002</partinfo>. Screen the clone.


How to perform genome integration

The integration into the E. coli chromosome can exploit the bacteriophage attP-mediated integration or the homologous recombination.

Detailed protocols about attP-mediated integration can be found here:

  • Anderson JC et al., 2010
  • Haldimann A and Wanner BL, 2001

Detailed protocols about homologous recombination can be found here:

  • Martinez-Morales F et al., 1999
  • Posfai G et al., 1997


When using the default integration guide <partinfo>BBa_K300991</partinfo>, the integration method relies on the bacteriophage site-specific recombination (attP-mediated recombination) through the attP site on the integrative vector and the attB site in the host genome.

This integration method is applicable when the host strain does not have prophages in the att(Phi80) locus. TOP10 (<partinfo>BBa_V1009</partinfo>) and DH5alpha (<partinfo>BBa_V1001</partinfo>) strains have the Phi80 prophage and so their chromosome cannot be engineered with this procedure.

The genomic integration of the desired BioBrick part into the attP(Phi80) locus has to be mediated by co-transforming a helper plasmid, such as the Amp-resistant <partinfo>BBa_J72008</partinfo> plasmid, which carries the IntPhi80 site-specific integrase gene under the control of a thermoinducible promoter (see Fig.14). The helper plasmid also has a heat-sensitive replication origin, whose replication can be inhibited at temperatures of 37-42°C, while a permissive temperature for this vector is 30°C. For this reason, it can be cured at high temperatures, when the integrase expression is triggered at the same time. The Phi80 integrase mediates the site-specific recombination between the attP site in the integrative vector and the attB site in the bacterial genome (for a schematic description of this process, see Fig.15 and http://partsregistry.org/Recombination).

Figure 14: Schematic description of the <partinfo>BBa_J72008</partinfo> plasmid. cI857 is the expression system for the thermoinducible cI repressor; int is the Phi80 integrase regulated by the lambda cI-repressible promoter; pir is the expression system for the pir-116 gene which is able to trigger the propagation of the R6K conditional replication origin; ori_ts is the heat-sensitive replication origin (low copy) of the vector; bla is the Ampicillin resistance marker.
Figure 15: Schematic description of site-specific recombination between a bacteriophage attP attachment site in the plasmid and an attB attachment site in the bacterial genome. In this way the sequence of interest (called "Part" in the figure) can be stably integrated into the attB genomic locus. This process is mediated by a specific integrase.

Thanks to its R6K conditional replication origin, the integrative vector cannot be replicated in common E. coli strains, so the Chloramphenicol resistant bacteria are actual integrants.

In the Materials and Methods section (https://2010.igem.org/Team:UNIPV-Pavia/Project/results), a detailed protocol to target the desired BioBrick part into the Phi80 locus is reported.

How to perform multiple integrations in the same genome

When this vector is integrated in the genome, the desired passenger should be maintained into the host, as well as the Chloramphenicol resistance marker and the R6K conditional replication origin. The CmR and the R6K can be excised from the genome by exploiting the two FRT recombination sites that flank them. The Flp recombinase protein mediates this recombination event (for a schematic description of this process, see Fig.16 and http://partsregistry.org/Recombination), so it has to be expressed by a helper plasmid, such as pCP20 (CGSC#7629). This enables the sequential integration of several parts using the same antibiotic resistance marker, which can be each time eliminated.


Detailed protocols about homologous recombination can be found here:

  • Cherepanov PP and Wackernagel W, 1995
  • Datsenko KA and Wanner BL, 2000


Figure 16: Schematic description of direct repeat-recombination between two FRT sites which flank the R6K-CmR DNA. In this way, the R6K-CmR DNA is excised from the construct and a single FRT site remains in the molecule. This process is mediated by a specific recombinase, the Flp recombinase, which recognizes the FRT sites.


Integrative standard vector for yeast

Here, a detailed description of the integrative vector for the yeast S. cerevisiae is reported.

The structure of the designed vector, here named <partinfo>BBa_K300001</partinfo>, is shown in Fig.17. Most of its features have been inspired by the pUG6 plasmid (GenBank: AF298793.1), constructed by [Guldener U et al., 1996]. The parts notation is reported in Fig.18.

Figure 17: BioBrick integrative base vector <partinfo>BBa_K300001</partinfo>.
Figure 18: Parts notation.

This is an integrative vector which can be used to insert the desired RFC10-compatible BioBrick parts/devices/systems into the genome of S. cerevisiae. This vector can also be specialized to target the desired integration site in the host genome.

The default version of this backbone targets the Gal system of the S288C strain (<partinfo>BBa_K300979</partinfo>) through the two homologous regions <partinfo>BBa_K300986</partinfo> and <partinfo>BBa_K300987</partinfo>. The Gal system is not essential for yeast survival if the strain is grown on carbon sources other than galactose.

This vector enables multiple integrations in different positions of the same genome. The usage of the KanMX dominant selection marker can avoid the usage of auxotrophic markers. In the industrial framework auxotrophies are usually deleterious for the process productivity because they affect the growth rate of cells. For this reason, this vector can be a concrete solution for the design of industrial yeast strains with novel user-defined functions.


Glossary

A HR (Homologous Region) is a sequence that can recombine with the host genome.

As explained for the integrative vector for E. coli, the passenger is the desired DNA part to be integrated into the genome.

Design features

This vector backbone was designed as a modular integrative vector for S. cerevisiae. In this section, the main design features for vector engineering and for the genome integration of the vector are reported.


Vector engineering features:

  1. The cloning site is not the same as other RFC10 compatible vectors. It contains a RFC10 BioBrick Prefix (<partinfo>BBa_G00000</partinfo>) and a SpeI restriction site instead of the original BioBrick Suffix. However, the presence of unique EcoRI and SpeI sites in the cloning site fully supports the assembly of the desired BioBrick parts in the cloning site upon EcoRI-SpeI digestion. This design feature has been forced by the presence of illegal XbaI and PstI sites in the TEF promoter in the LoxP-KanMX-LoxP cassette (<partinfo>BBa_K300989</partinfo>). This vector does not support the 3A Assembly.
  2. The two NheI sites and the two AvrII sites flanking the default HR integration sequences <partinfo>BBa_K300986</partinfo> and <partinfo>BBa_K300987</partinfo> enable the engineering of this backbone by assembling new user-defined BioBrick integration sequences upon XbaI-SpeI digestion.
  3. This vector can be propagated in E. coli at high copy thanks to the pMB1 replication origin and the Ampicillin resistance marker present in <partinfo>pSB1A2</partinfo> (=<partinfo>BBa_K300988</partinfo>), that is one of the standard parts that compose this integrative vector.
  4. Standard verification primer binding sites VF2 (<partinfo>BBa_G00100</partinfo>) and VR (<partinfo>BBa_G00102</partinfo>) are present in the <partinfo>pSB1A2</partinfo> (=<partinfo>BBa_K300988</partinfo>) backbone. They can be used to verify the vector length and sequence comprised between the two integration sites.


Genome integration features:

  1. The LoxP-KanMX-LoxP cassette (<partinfo>BBa_K300989</partinfo>) enables the selection of positive yeast integrants on YPD agar plates supplemented with 200 ug/ml of G418 geneticin. Once integrated, this cassette can be excised upon Cre recombinase activity. This allows to perform multiple integrations in the same strain, always using the same dominant G418 resistance marker.
  2. The heterologous modules in the LoxP-KanMX-LoxP cassette (<partinfo>BBa_K300989</partinfo>), i.e. the TEF promoter and the TEF transcriptional terminator from A. gossypii and the KanR from the Tn903 transposon of E. coli, show a very low homology with the S. cerevisiae genome. For this reason, the vector integration events in unwanted positions in the yeast genome are limited.

How to use it

<partinfo>BBa_K300001</partinfo> can be:

  • propagated in E. coli
  • engineered to change the passenger part and/or the HRs.
  • integrated into the desired locus of the host genome
  • used to perform the desired number of serial integrations in the same genome


How to propagate it before performing genome integration

This vector can be easily propagated in E. coli thanks to the high-copy replication origin and the Ampicillin resistance selection marker, both derived from the <partinfo>pSB1A2</partinfo> vector backbone.


How to integrate a BioBrick into the yeast genome

  1. Digest <partinfo>BBa_K300001</partinfo> and the desired BioBrick part with EcoRI-SpeI and ligate them (Fig.19).
  2. Propagate the resulting plasmid in E. coli and extract plasmid DNA from bacteria.
  3. Digest the resulting plasmid with SbfI to linearize the DNA of interest (Fig.20). This is known to increase the integration efficiency from 10- to 50-fold when compared to a non-linearized DNA [http://partsregistry.org/Part:BBa_K300001:Design#References Reference 11].
  4. Transform the linearized plasmid into S. cerevisiae and select integrants on G418 antibiotic plates (Fig.21).
Figure 19: Assembly of the desired BioBrick part into the integrative vector.
Figure 20: The plasmid can be linearized upon SbfI digestion to separate the yeast DNA fragment (containing the part of interest and the LoxP-KanMX-LoxP cassette) from the E. coli DNA fragment (containing the replication origin and the Amp resistance).
Figure 21: Integration of the BioBrick of interest into the S. cerevisiae genome by homologous recombination. In this figure, the integration in the Gal system genomic region is shown.

Users can change the integration site by engineering the vector: <partinfo>BBa_K300986</partinfo> and <partinfo>BBa_K300987</partinfo> are flanked by two AvrII and two NheI respectively and for this reason the two Homologous Regions can be excided. New homologous sequences compatible with RFC10 can be digested with XbaI-SpeI and assembled because AvrII, NheI, XbaI and SpeI have compatible sticky ends. Note that this assembly is not directional and the correct orientation can be validated through sequencing with standard VF2 and VR primers.


How to perform the KanMX marker excision

The KanMX dominant selection marker is flanked by two loxP recombination sites and for this reason it can be excided upon Cre recombinase activity (Fig.22). The Cre recombinase has to be expressed by a helper plasmid.


Figure 22: KanMX excision with loxP sites recombination. For more details about this process, see http://partsregistry.org/Recombination


Self-cleaving affinity tags to easily purify proteins

Conventional affinity-based protein purification methods rely on specific binding of the fusion tag to an immobilized ligand, but they are affected by severe limitations, as explained in the Motivation section. Briefly, they imply the use of expensive proteases for tag removal from the fusion protein, requiring the appropriate aminoacidic sequence to be included between the tag and the target protein. Moreover, the cost of the affinity resins used in the process is far from negligible, especially on industrial scale.

The use of self-cleaving protein elements coupled with innovative affinity tags has been recently proposed to overcome these limitations. For all these reasons, in this section a technique compliant to the BioBrick assembly standard and based on self-splicing affinity tags derived from the fusion of Phasins, Inteins and a short flexible linker is proposed.

Tag

Phasin

Phasins are proteins involved in formation and stabilization of PolyHydroxyAlkanoates (PHA), intracytoplasmic inclusions in microorganisms like Ralstonia eutropha which serve as carbon and energy storage. As such, Phasins exhibit highly specific binding to PHA granules and can be used to create tags for proteins, while PHB can be used as the affinity matrix.

In literature, it has also been shown that the Phasin-tagged fusion protein's affinity with PHA granules can be improved by increasing the number of Phasins in the fusion protein.

The Ralstonia eutropha‘s Phasin coding sequence, <partinfo>K208001</partinfo>, was already present in the Registry in Silver standard. However, at the end of this gene there was a TGA stop codon which prevents the usage of this Phasin as a head or internal domain.

In order to overcome this problem, <partinfo>K208001</partinfo> has been improved for fusion protein applications by mutagenesis through PCR using custom primers. Two new BioBrick parts were built and submitted to the Registry:

  • <partinfo>BBa_K300002</partinfo>: Phasin - head domain (removed stop codon; Assembly Standard 10 prefix; Silver Standard suffix)
  • <partinfo>BBa_K300003</partinfo>: Phasin - internal domain (removed stop codon; Silver Standard prefix; Silver Standard suffix)

These two new parts allow the construction of composite synthetic affinity tags, built by assembling an arbitrary number of Phasins (it has been shown that a better affinity is achieved by fusing of two or more Phasins). In this work a flexible linker sequence (<partinfo>BBa_K105012</partinfo>) that connects the Phasins has also been used in order to test if it can improve or facilitate the binding and folding of the tag.

PHA production

PHA production in R. eutropha is achieved by the PhaCAB operon, which contains three genes, phbC, phbA and phbB, each encoding for an enzyme essential for the formation of polyhydroxybutyrate (PHB, a kind of polyhydroxyalkanoate) inclusions. In literature, the production of PHB has already been achieved in E. coli by incorporating the PhaCAB operon. The PHB granules produced by engineered E. coli can be used as an affinity matrix for Phasin-based affinity tags and the binding of the Phasin-tagged protein of interest can occur in vivo.

Several parts for PHB production are present in the Registry: in the past iGEM editions, the Duke (2008 and 2009), Hawaii (2008), Tsinghua (2008), Virginia (2008) teams worked on it and submitted a set of BioBrick parts for PHB synthesis. However, the complete phaCAB operon is not available in the Registry. Because a lot of work about PHB has already been done and because our short term goal was not to optimize the PHB granules productions, an existing engineered E. coli strain able to produce PHB was used as a proof-of-concept affinity matrix producer. This strain comes from the DSMZ public collection and is named DMSZ15372.


Taking advantage of the natural affinity of Phasins to PHB, it is possible to engineer strains in which PHB and the Phasin-tagged protein of interest are co-produced and the binding can occur. The overall yield and specificity of the process depends on the structure of the Phasin-based tags, which can be easily constructed or modified by using BioBrick parts compatible with the common RFC10 and RFC23 standards to perform in-frame assemblies.

For this reason these tags are modular and can be freely expanded; a generic one is shown in Fig.23.

Figure 23: Generic tag composed by two Phasin coding sequences separated by a flexible peptide linker coding sequence.

Protein purification system

Phasins and PHB granules can replace the common affinity tags and matrix respectively. However, expensive proteases are still essential to remove the tag after the Phasins-PHB binding. A novel engineered inducible Intein can be used to complete the purification process by removing the affinity tag, thus replacing proteases.

Intein

Inteins (Intervening Proteins) are sequences capable of self-exciding from a precursor protein through a process known as self-splicing, forming a peptide bond between the flanking proteins (exteins). Many so-called mini-Inteins have been engineered, whose key feature is the capability to completely release a flanking extein (the target protein) in response to a simple stimulus, either chemical or physical, with no need of expensive proteases.

In literature, one mini-Intein was obtained through mutagenesis of Mycobacterium tuberculosis Mtu RecA Intein. The sequence of this Intein, referred to as ΔI-CM, allows for pH/heat-controlled C-terminal cleavage.

Thanks to this feature, the ΔI-CM Intein can be fused downstream of an affinity tag and upstream of the protein coding sequence of interest in order to enable a cheap cleavage process to remove the N-terminal tag.

In this project, the ΔI-CM Intein sequence was designed according to [Wood DW et al., 1999] and codon-optimized for E. coli to yield <partinfo>BBa_K300004</partinfo>. This part was designed as an internal domain (prefix and suffix compatible with Silver standard) in order to enable protein coding sequence assemblies to generate the desired synthetic self-cleavable affinity tags for protein purification.


Thus, it is possible to create an engineered protein purification system that uses the tag construct and relies on Intein self-cleaving capabilities. Fig.24 shows a generic purification tag, composed by Phasins and Intein, as an example.

Figure 24: Generic purification system.

Protein purification takes place as follows:

1. Affinity tag (and consequently fused protein) binding to PolyHydroxyAlkanoates (Fig.25).
Figure 25: In vivo binding activity.
2. Cells lysis.
3. Recovery of the fused protein, bound with PHA granules, by centrifugation.
4. Elution in the supernatant of the target protein by Intein cleavage through a pH or heat stimulus (Fig.26).
Figure 26: Purification.